Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Resideo Technologies (REZI) EBITDA (2017 - 2025)

Historic EBITDA for Resideo Technologies (REZI) over the last 9 years, with Q3 2025 value amounting to $154.0 million.

  • Resideo Technologies' EBITDA rose 2222.22% to $154.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $611.0 million, marking a year-over-year increase of 1682.6%. This contributed to the annual value of $520.0 million for FY2024, which is 493.6% down from last year.
  • As of Q3 2025, Resideo Technologies' EBITDA stood at $154.0 million, which was up 2222.22% from $177.0 million recorded in Q2 2025.
  • Resideo Technologies' 5-year EBITDA high stood at $186.0 million for Q3 2022, and its period low was $98.0 million during Q4 2022.
  • In the last 5 years, Resideo Technologies' EBITDA had a median value of $141.0 million in 2021 and averaged $142.3 million.
  • In the last 5 years, Resideo Technologies' EBITDA soared by 211666.67% in 2021 and then plummeted by 3049.65% in 2022.
  • Quarter analysis of 5 years shows Resideo Technologies' EBITDA stood at $141.0 million in 2021, then tumbled by 30.5% to $98.0 million in 2022, then skyrocketed by 50.0% to $147.0 million in 2023, then fell by 2.04% to $144.0 million in 2024, then rose by 6.94% to $154.0 million in 2025.
  • Its EBITDA stands at $154.0 million for Q3 2025, versus $177.0 million for Q2 2025 and $136.0 million for Q1 2025.